Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

5.280 -0.180 (-3.30%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	27,550
Open	5.340
Bid (Size)	5.200 (1,000)
Ask (Size)	5.800 (400)
Prev. Close	5.460
Today's Range	5.200 - 5.548
52wk Range	5.200 - 1,444.50
Shares Outstanding	596,978
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results

November 14, 2025

From Enveric Biosciences

Via Business Wire

Which stocks are moving on Monday? ↗

November 03, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Performance

YTD	-99.5%	-99.5%
1 Month	-51.1%	-51.1%
3 Month	-60.0%	-60.0%
6 Month	-66.2%	-66.2%
1 Year	-99.5%	-99.5%

More News

Enveric Biosciences Announces Reverse Stock Split

October 23, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance

October 16, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal

October 15, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences to Explore Digital Asset Treasury Opportunities

October 14, 2025

From Enveric Biosciences

Via Business Wire

These stocks are gapping in today's session ↗

October 03, 2025

Via Chartmill

These stocks that are showing activity before the opening bell on Friday. ↗

October 03, 2025

Via Chartmill

Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials

October 02, 2025

From Enveric Biosciences

Via Business Wire

Stay updated with the stocks that are on the move in today's pre-market session. ↗

September 30, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 29, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's after-hours session. ↗

September 29, 2025

Via Chartmill

Enveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds

September 18, 2025

From Enveric Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 17, 2025

Via Benzinga

Which stocks are experiencing notable movement on Wednesday? ↗

September 17, 2025

Via Chartmill

Wednesday's session: gap up and gap down stocks ↗

September 17, 2025

Via Chartmill

Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds

September 17, 2025

From Enveric Biosciences, Inc.

Via Business Wire

Enveric Biosciences Announces Publication of Two Peer-Reviewed Articles Highlighting Novel Bioproduction Methods for Neuropsychiatric Drug Discovery

September 17, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission

September 16, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference

September 03, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Relocates Corporate Headquarters to Cambridge, MA

September 02, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Successfully Completes Pre-IND Dose Range Finding Studies for Lead Candidate EB-003, Targeting Neuropsychiatric Indications

August 28, 2025

From Enveric Biosciences, Inc.

Via Business Wire

Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate Results

August 14, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series

July 23, 2025

From Enveric Biosciences

Via Business Wire

Enveric Biosciences Lead Drug Candidate EB-003 Demonstrates Positive Effects in Preclinical Model of Post-Traumatic Stress Disorder (PTSD)

July 15, 2025

From Enveric Biosciences

Via Business Wire

Frequently Asked Questions

Is Enveric Biosciences, Inc. - Common Stock publicly traded?

Yes, Enveric Biosciences, Inc. - Common Stock is publicly traded.

What exchange does Enveric Biosciences, Inc. - Common Stock trade on?

Enveric Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Enveric Biosciences, Inc. - Common Stock?

The ticker symbol for Enveric Biosciences, Inc. - Common Stock is ENVB on the Nasdaq Stock Market

What is the current price of Enveric Biosciences, Inc. - Common Stock?

The current price of Enveric Biosciences, Inc. - Common Stock is 5.280

When was Enveric Biosciences, Inc. - Common Stock last traded?

The last trade of Enveric Biosciences, Inc. - Common Stock was at 11/14/25 04:00 PM ET

What is the market capitalization of Enveric Biosciences, Inc. - Common Stock?

The market capitalization of Enveric Biosciences, Inc. - Common Stock is 3.15M

How many shares of Enveric Biosciences, Inc. - Common Stock are outstanding?

Enveric Biosciences, Inc. - Common Stock has 3M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.